🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Se...
Status
Active Not Recruiting
Location
Arkansas Diagnostic Center
Start Date
2017-12-12
Trial ID
NCT03301506
Treatments Being Tested
A Multicenter Randomized, Double-Blind, Placebo-Controlled Study to evaluat...
Status
Completed
Location
Radiant Research
Start Date
2007-08
Trial ID
NCT00701883
The objectives of this study are to evaluate the effect of seladelpar treat...
Status
Terminated
Location
Sutter Pacific Medical Foundation - California Pacific Medical Center
Start Date
2019-11-12
Trial ID
NCT04024813
Treatments Being Tested
A Phase 2, Double-Blind (DB), Randomized, Placebo-Controlled Study Followed...
Status
Terminated
Location
CymaBay Research Site
Start Date
2018-04-30
Trial ID
NCT03551522
Treatments Being Tested
An 8-week, dose ranging, open label, randomized, Phase 2 study with a 44-we...
Status
Completed
Location
Institute for Liver Health
Start Date
2016-11-28
Trial ID
NCT02955602
Treatments Being Tested
A 12-week, open-label, dose-escalating, phase 2 study to evaluate the effec...
Status
Completed
Location
Ecogene-21
Start Date
2015-04
Trial ID
NCT02472535
The primary objective of this study is to evaluate the effect of seladelpar...
Status
Terminated
Location
Mayo Clinic of Arizona
Start Date
2015-11-04
Trial ID
NCT02609048
Treatments Being Tested